Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
When Direct Health-Care Professional Communications Have an Impact on Inappropriate and Unsafe Use of MedicinesReber, K C ; Piening, S ; Wieringa, J E ; Straus, S M J M ; Raine, J M ; de Graeff, P A ; Haaijer-Ruskamp, F M ; Mol, P G MClinical pharmacology and therapeutics, 2013-04, Vol.93 (4), p.360-365 [Periódico revisado por pares]Basingstoke: Blackwell Publishing LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Impact of Safety-Related Regulatory Action on Clinical Practice: A Systematic ReviewPiening, Sigrid ; Haaijer-Ruskamp, Flora M. ; de Vries, Jonie T. N. ; van der Elst, Menno E. ; de Graeff, Pieter A. ; Straus, Sabine M. J. M. ; Mol, Peter G. M.Drug safety, 2012-05, Vol.35 (5), p.373-385 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Additional safety risk to exceptionally approved drugs in Europe?Arnardottir, Arna H. ; Haaijer‐Ruskamp, Flora M. ; Straus, Sabine M. J. ; Eichler, Hans‐Georg ; de Graeff, Pieter A. ; Mol, Peter G. M.British journal of clinical pharmacology, 2011-09, Vol.72 (3), p.490-499 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the NetherlandsPiening, Sigrid ; de Graeff, Pieter A. ; Straus, Sabine M. J. M. ; Haaijer-Ruskamp, Flora M. ; Mol, Peter G. M.Drug safety, 2013-09, Vol.36 (9), p.723-731 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Effect of Safety Issues with HIV Drugs on the Approval Process of Other Drugs in the Same Class: An Analysis of European Public Assessment ReportsArnardottir, Arna H. ; Haaijer-Ruskamp, Flora M. ; Straus, Sabine M. J. ; de Graeff, Pieter A. ; Mol, Peter G. M.Drug safety, 2011-11, Vol.34 (11), p.1101-1114 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment : a multilevel studyKASJE, Willeke N ; DENIG, Petra ; STEWART, Roy E ; DE. GRAEFF, Pieter A ; HAAIJER-RUSKAMP, Flora MEuropean journal of clinical pharmacology, 2005-04, Vol.61 (2), p.145-151 [Periódico revisado por pares]Heidelberg: SpringerTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Cardiovascular drugs: discrepancies in demographics between pre- and post-registration useWIERINGA, N. F ; DE GRAEFF, P. A ; VAN DER WERF, G. T ; VOS, REuropean journal of clinical pharmacology, 1999-09, Vol.55 (7), p.537-544 [Periódico revisado por pares]Heidelberg: SpringerTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelinesFIJN, R ; STUURMAN-BIEZE, A. G. G ; VAN DEN BERG, P. B ; BROUWERS, J. R. B. J ; DE GRAEFF, P. A ; DE JONG-VAN DEN BERG, L. T. WEuropean journal of clinical pharmacology, 2000-12, Vol.56 (9-10), p.739-746 [Periódico revisado por pares]Heidelberg: SpringerTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498VAN GILST, W. H ; DE GRAEFF, P. A ; WESSELING, H ; DE LANGEN, C. D. JJournal of cardiovascular pharmacology, 1986-07, Vol.8 (4), p.722-728 [Periódico revisado por pares]Philadelphia, PA: LippincottTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Effect of Quinapril and Triamterene/Hydrochlorothiazide on Cardiac and Vascular End-Organ Damage in Isolated Systolic HypertensionHeesen, Wilfred F ; Beltman, Frank W ; Smit, Andries J ; May, Johan F ; de Graeff, Pieter A ; Havinga, Tjeerd K ; Schuurman, Frits H ; van der Veur, Enno ; Meyboom-de Jong, Betty ; Lie, Kong IJournal of cardiovascular pharmacology, 1998-02, Vol.31 (2), p.187-194 [Periódico revisado por pares]Philadelphia, PA: Lippincott-Raven PublishersTexto completo disponível |